pBCAR3/pIRS2-Phosphopeptide-tetanus Peptide Vaccine

A vaccine composed of phosphorylated peptides from the tumor associated antigens breast cancer anti-estrogen resistance-3 (BCAR3) and insulin receptor substrate-2 (IRS2) and a tetanus-derived peptide, with potential immunomodulating and antineoplastic activities. Upon administration of pBCAR3/pIRS2 phosphopeptide-tetanus peptide vaccine, the pBCAR3/pIRS2 phosphopeptide may stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing either phosphopeptide. The tetanus peptide serves as an immunoadjuvant and induces a helper T-cell response which may help stimulate an immune response against pBCAR3 and pIRS2-expressing melanoma tumor cells. BCAR3 and IRS2 are upregulated in a variety of cancer cells. (NCI Thesaurus)

YOU MAY ALSO LIKE

pBCAR3 Phosphopeptide-tetanus Peptide Vaccine

A vaccine composed of a phosphorylated peptide from the tumor associated antigen breast cancer anti-estrogen resistance-3 (BCAR3) and a tetanus-derived peptide, with…

Pb4+

Lead ion requiring four electrons to return to its elemental state.

Pb2+

Lead ion requiring two electrons to return to its elemental state.

Pazopanib hydrochloride

A drug used to treat advanced renal cell carcinoma, which is the most common type of kidney cancer. It is also used…

Pazopanib

A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1,…

Payment Method Code

A coded value specifying the method by which payment is delivered.